ARCHIVES

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

This article is from The Cancer Letter archive.

Vol. 30 No. 23 | June 4, 2004

Download PDF Visit The Full Archive

Related Articles

New ACS Grants to Fund ‘Critical, Urgent’ Research

April 15, 1977

RFAs For Extramural Construction, Mouse Facility Available

March 2, 1990

Onco TCS Induces Responses In Relapsed Aggressive NHL

February 28, 2003

Tarceva Added To Gemcitabine Improves Pancreatic Cancer Survival, Study Finds

February 25, 2005

Long-term Hormonal Therapy Adds No Additional Benefits

September 27, 2013

PET Better At Evaluating Response In Sarcoma

February 29, 2008